Quotes 5-day view Delayed Nyse
06/02/2023
06/05/2023
06/06/2023
06/07/2023
06/08/2023
Date
146.52(c)
145.94(c)
144.49(c)
144.8(c)
146.44
Last
6 124 403
4 753 665
4 636 045
6 194 620
4 864 149
Volume
+1.78%
-0.40%
-0.99%
+0.21%
+1.13%
Change
Estimated financial data (e) (USD)
Sales 2023
81 482 M
-
-
Net income 2023
14 603 M
-
-
Net Debt 2023
27 400 M
-
-
P/E ratio 2023
24,6x
Yield 2023
2,55%
Sales 2024
85 151 M
-
-
Net income 2024
15 628 M
-
-
Net Debt 2024
28 050 M
-
-
P/E ratio 2024
22,7x
Yield 2024
2,68%
Capitalization
341 B
341 B
-
EV / Sales 2023
4,52x
EV / Sales 2024
4,34x
Nbr of Employees
106 000
Free-Float
58,8%
Procter & Gamble Company is one of the world's leaders in producing and selling consumer products. Net sales break down by family of products as follows:
- care and hygiene products (38.1%): oral hygiene products (toothpastes, toothbrushes, mouthwashes, etc.; Crest, Oral-B, Scope brands, etc.), pharmaceutical products (Metamucil, Neurobion, Pepto Bismol, Vicks, etc.), toilet training pants (Luvs, Pampers), toilet...
Ratings of Procter & Gamble Company
All news about PROCTER & GAMBLE COMPANY
News in other languages on PROCTER & GAMBLE COMPANY
Analyst Recommendations on PROCTER & GAMBLE COMPANY
ETFs positioned on PROCTER & GAMBLE COMPANY ETFs and Trackers with Trackinsight
ETF Overview: Value, Nasdaq-100, Low Volatility
Chart PROCTER & GAMBLE COMPANY
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends PROCTER & GAMBLE COMPANY
Short Term Mid-Term Long Term Trends Bearish Neutral Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
144,80 $
Average target price
165,19 $
Spread / Average Target
14,1%
Please enable JavaScript in your browser's settings to use dynamic charts.